- 全部删除
- 您的购物车当前为空
Elgodipine 显著降低了运动诱导的心绞痛系统的发生率和严重程度,能够通过独立于转录因子c-fos 和c-jun 表达的机制抑制血管平滑肌增殖。 Elgodipine 诱导的抑制是电压依赖性的。Elgodipine 是治疗心绞痛的潜在化合物。
为众多的药物研发团队赋能,
让新药发现更简单!
Elgodipine 显著降低了运动诱导的心绞痛系统的发生率和严重程度,能够通过独立于转录因子c-fos 和c-jun 表达的机制抑制血管平滑肌增殖。 Elgodipine 诱导的抑制是电压依赖性的。Elgodipine 是治疗心绞痛的潜在化合物。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 540 | In stock | |
5 mg | ¥ 1,320 | In stock | |
10 mg | ¥ 1,980 | In stock | |
25 mg | ¥ 3,220 | In stock | |
50 mg | ¥ 4,680 | In stock | |
100 mg | ¥ 6,690 | In stock | |
200 mg | ¥ 8,930 | In stock |
产品描述 | Elgodipine significantly reduced the incidence and severity of exercise-induced angina pectoris systemically and was able to inhibit vascular smooth muscle proliferation through a mechanism independent of the expression of the transcription factors c-fos and c-jun. The Elgodipine-induced inhibition was voltage-dependent. Elgodipine is a potential compound for the treatment of angina pectoris. |
靶点活性 | Ca2+ channel:0.33 µM |
体内活性 | Elgodipine(64微克/千克;静脉注射;22名患者)显著降低了全身血管阻力以及收缩压和舒张压,同时增加了心输出量和每搏输出量。无论是在静息状态还是运动期间,Elgodipine对心率均无影响。[1] |
别名 | 依高地平 |
分子量 | 524.58 |
分子式 | C29H33FN2O6 |
CAS No. | 119413-55-7 |
Smiles | C(OCCN(CC1=CC=C(F)C=C1)C)(=O)C=2C(C(C(OC(C)C)=O)=C(C)NC2C)C3=C4C(=CC=C3)OCO4 |
存储 | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 55 mg/mL (104.85 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容